Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression

Oncotarget - United States
doi 10.18632/oncotarget.26586
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells

Oncotarget
Oncology
2016English

Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2

Oncology Reports
MedicineCancer ResearchOncology
2018English

Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Hypoxia Induces Downregulation of Soluble Guanylyl Cyclase 1 by miR-34c-5p

Journal of Cell Science
Cell Biology
2012English

Downregulation of miR-145-5p in Cancer Cells�and Their�derived Exosomes May Contribute To�the�development of Ovarian Cancer by Targeting CT

International Journal of Molecular Medicine
MedicineGenetics
2018English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

Hypoxia-Induced Up-Regulation of miR-27a Promotes Paclitaxel Resistance in Ovarian Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

MiR–20a-5p Promotes Radio-Resistance by Targeting Rab27B in Nasopharyngeal Cancer Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

miR-509-5p Inhibits Cellular Proliferation and Migration via Targeting MDM2 in Pancreatic Cancer Cells

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy